Regeneron Pharmaceuticals
REGN
REGN
701 hedge funds and large institutions have $27.7B invested in Regeneron Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 136 funds opening new positions, 205 increasing their positions, 249 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.17% more ownership
Funds ownership: 68.3% → 68.47% (+0.17%)
16% less call options, than puts
Call options by funds: $773M | Put options by funds: $924M
18% less repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 249
Holders
701
Holding in Top 10
16
Calls
$773M
Puts
$924M
Top Buyers
| 1 | +$287M | |
| 2 | +$202M | |
| 3 | +$185M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$181M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$178M |
Top Sellers
| 1 | -$377M | |
| 2 | -$180M | |
| 3 | -$122M | |
| 4 |
Millennium Management
New York
|
-$92.5M |
| 5 |
Two Sigma Advisers
New York
|
-$91.7M |